![Daniel Bensen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Bensen
Fondatore presso
TYRA BIOSCIENCES, INC.
Patrimonio netto: 5 M $ in data 31/05/2026
Profilo
Daniel Bensen is the founder of Tyra Biosciences, Inc., founded in 2018, and holds the title of Chief Discovery Officer since 2025.
Former jobs include Principal Scientist at Trius Therapeutics, Inc. from 2007 to 2014, and Head-Immunology & Protein Chemistry at Cidara Therapeutics, Inc. from 2014 to 2018.
Education includes an undergraduate degree from Point Loma Nazarene University and an MBA from USC Marshall School of Business.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
TYRA BIOSCIENCE, INC 0,25% | 12/02/2026 | 146.981 ( 0,25% ) | 5 M $ | 31/05/2026 |
Posizioni attive di Daniel Bensen
| Società | Posizione | Inizio |
|---|---|---|
| TYRA BIOSCIENCES, INC. | Fondatore | 02/08/2018 |
Precedenti posizioni note di Daniel Bensen
| Società | Posizione | Fine |
|---|---|---|
| CIDARA THERAPEUTICS | Corporate Officer/Principal | 01/11/2018 |
Trius Therapeutics, Inc.
 Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Corporate Officer/Principal | 01/02/2014 |
Formazione di Daniel Bensen
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
33
Relazioni di 1° grado
5
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Point Loma Nazarene University
 Point Loma Nazarene University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Health Technology |
USC Marshall School of Business
 USC Marshall School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cidara Therapeutics, Inc.
 Cidara Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Engages in the discovery, development, and commercialization of novel anti-infectives | Health Technology |
Tyra Biosciences, Inc.
 Tyra Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops cancer treatment drug therapies | Health Technology |
